Amid Global Pandemic, Launch of Smart Safety Syringe to Maximize Availability of Life-Saving Medicine NEW YORK, July 06, 2020 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., today announced plans to manufacture its patented SHARPS PROVENSA™ smart safety syringes for use throughout the United States. ...

Biothera Pharmaceuticals Commences Phase 2 Head and Neck Cancer Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA® (pembrolizumab) EAGAN, Minn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. announced today that patient treatment has commenced in its Phase 2 clinical study in squamous cell carcinoma of the...